Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FQ2RP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,410
Award facts
- Contract value 100% obligated
- $19,410.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $19,410.01 delivery order to AmerisourceBergen Drug Corp for DUPIXENT 300 mg/2 ml pen injectable medication on September 10, 2025, with completion scheduled for September 11, 2025. This competitively awarded, firm fixed-price delivery order represents a single-transaction purchase with no set-aside designation. The award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total value of $999,999,999.00 and extends through December 2026. The pharmaceutical will be sourced from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp serves as a primary pharmaceutical distributor for federal medical procurement, supporting military and veteran healthcare systems through the DLA Medical Supply Chain. The SPE2DX IDC functions as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. This delivery order for DUPIXENT, a biologic treatment commonly prescribed for eczema, asthma, and other allergic conditions, demonstrates the company's role in fulfilling federal medical supply requirements through open competition across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FQ2RP?
SPE2DB25FQ2RP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 10, 2025.
How much is contract SPE2DB25FQ2RP worth?
The government has obligated $19,410 on SPE2DB25FQ2RP.
Is contract SPE2DB25FQ2RP an order under another contract?
Yes. SPE2DB25FQ2RP is a delivery order under SPE2DB22D3011, an indefinite delivery contract.
Was contract SPE2DB25FQ2RP competed?
The extent of competition for SPE2DB25FQ2RP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award